Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
December 12, 2001

Pfizer Has Recalled Rescriptor 200 mg tablets

New York, NY (SafetyAlerts) - The Food and Drug Administration (FDA) said that Pfizer Inc. has recalled Rescriptor 200 mg tablets (delavirdine mesylate tablets).

This is the first public notice of this Class lI recall issued by the FDA.

PRODUCT
Rescriptor 200 mg tablets (delavirdine mesylate tablets), NDC 0009-7576-01, Bottles of 180 tablets, Recall # D-041-2.

CODE
Lot no. 17DSJ Exp. date 11/01.

RECALLING FIRM/MANUFACTURER
Recalling Firm:
Pfizer Inc., New York, NY, by letter on 10/26/01.

Manufacturer:
Pharmacai & UpJohn Barceloneta, Puerto Rico. Firm initiated recall is ongoing.

REASON
Lowered therapeutic effectiveness.

VOLUME OF PRODUCT IN COMMERCE
1,949 bottles.

DISTRIBUTION
Nationwide
.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.